Literature DB >> 14742882

Position statement : executive summary. The Writing Group for the International Society for Clinical Densitometry (ISCD) Position Development Conference.

.   

Abstract

The International Society for Clinical Densitometry (ISCD) held a Position Development Conference in July 2003, at which time positions developed and researched by the organization's Scientific Advisory Committee were presented to a panel of international experts in the field of bone density testing. This panel reached agreement on a series of positions that were subsequently approved by the Board of Directors of the ISCD and are now official policy of the ISCD. These positions, which are outlined in this article and discussed in greater detail in subsequent articles in this journal, include (1) affirmation of the use of the World Health Organization classification for the diagnosis of osteoporosis in postmenopausal women; (2) the diagnosis of osteoporosis in men; (3) the diagnosis of osteoporosis in premenopausal women; (4) the diagnosis of osteoporosis in children; (5) technical standards for skeletal regions of interest by dual-energy X-ray absorptiometry (DXA); (6) the use of new technologies, such as vertebral fracture assessment; (7) technical standards for quality assurance, including phantom scanning and calibration; (8) technical standards for the performance of precision assessment at bone density testing centers, and for cross-calibration of DXA devices; (9) indications for bone density testing; (10) appropriate information for a bone density report; and (11) nomenclature and decimal places for bone density reporting.

Entities:  

Mesh:

Year:  2004        PMID: 14742882     DOI: 10.1385/jcd:7:1:7

Source DB:  PubMed          Journal:  J Clin Densitom        ISSN: 1094-6950            Impact factor:   2.963


  16 in total

Review 1.  Guidelines for the management of osteoporosis: the present and the future.

Authors:  Juliet Compston
Journal:  Osteoporos Int       Date:  2005-06-28       Impact factor: 4.507

Review 2.  Treatment of low bone mass in premenopausal women: when may it be appropriate?

Authors:  Edward S Leib
Journal:  Curr Osteoporos Rep       Date:  2005-03       Impact factor: 5.096

3.  Evaluation of the patient positioning during DXA measurements in daily clinical practice.

Authors:  Alp Cetin; Erkan Ozgüçlü; Levent Ozçakar; Ayşen Akinci
Journal:  Clin Rheumatol       Date:  2007-10-27       Impact factor: 2.980

4.  Clinical utility of spine bone density in elderly women.

Authors:  Diane L Schneider; Ricki Bettencourt; Elizabeth Barrett-Connor
Journal:  J Clin Densitom       Date:  2006 Jul-Sep       Impact factor: 2.617

Review 5.  Osteoporosis, frailty and fracture: implications for case finding and therapy.

Authors:  Joop P van den Bergh; Tineke A van Geel; Piet P Geusens
Journal:  Nat Rev Rheumatol       Date:  2012-01-17       Impact factor: 20.543

6.  Improving osteoporosis management in patients with fractures.

Authors:  S L Johnson; V I Petkov; M I Williams; P S Via; Robert A Adler
Journal:  Osteoporos Int       Date:  2004-12-07       Impact factor: 4.507

Review 7.  Special report on the official positions of the International Society for Clinical Densitometry.

Authors:  E M Lewiecki; D L Kendler; G M Kiebzak; P Schmeer; R L Prince; G El-Hajj Fuleihan; D Hans
Journal:  Osteoporos Int       Date:  2004-07-20       Impact factor: 4.507

8.  Low bone density in children with hypercalciuria and/or nephrolithiasis.

Authors:  Andrew L Schwaderer; Robert Cronin; John D Mahan; Carlton M Bates
Journal:  Pediatr Nephrol       Date:  2008-08-12       Impact factor: 3.714

9.  L-Carnitine, but not coenzyme Q10, enhances the anti-osteoporotic effect of atorvastatin in ovariectomized rats.

Authors:  Hussam A S Murad
Journal:  J Zhejiang Univ Sci B       Date:  2016-01       Impact factor: 3.066

10.  Longitudinal trends in use of bone mass measurement among older americans, 1999-2005.

Authors:  Jeffrey R Curtis; Laura Carbone; Hong Cheng; Burton Hayes; Andrew Laster; Robert Matthews; Kenneth G Saag; Robert Sepanski; Simpson B Tanner; Elizabeth Delzell
Journal:  J Bone Miner Res       Date:  2008-07       Impact factor: 6.741

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.